Survival analysis of first-line tamoxifen versus aromatase inhibitors for estrogen-positive metastatic breast cancer in postmenopausal women - a BC perspective

V. Kyritsis; M. De Lemos; Brian Walker; H. Kennecke; L. Nakashima

Survival analysis of first-line tamoxifen versus aromatase inhibitors for estrogen-positive metastatic breast cancer in postmenopausal women - a BC perspective

V. Kyritsis, M. De Lemos, Brian Walker, H. Kennecke, L. Nakashima

School of Pharmacy

Research output: Contribution to journal › Article › peer-review

Original language	English
Pages (from-to)	S112-S113
Number of pages	2
Journal	Breast Cancer Research and Treatment
Volume	106
Publication status	Published - 2007

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Cite this

@article{ac5ed266a79741228d4447efda425edb,

title = "Survival analysis of first-line tamoxifen versus aromatase inhibitors for estrogen-positive metastatic breast cancer in postmenopausal women - a BC perspective",

author = "V. Kyritsis and {De Lemos}, M. and Brian Walker and H. Kennecke and L. Nakashima",

year = "2007",

language = "English",

volume = "106",

pages = "S112--S113",

journal = "Breast Cancer Research and Treatment",

issn = "0167-6806",

publisher = "Springer New York",

}

Survival analysis of first-line tamoxifen versus aromatase inhibitors for estrogen-positive metastatic breast cancer in postmenopausal women - a BC perspective. / Kyritsis, V.; De Lemos, M.; Walker, Brian; Kennecke, H.; Nakashima, L.

In: Breast Cancer Research and Treatment, Vol. 106, 2007, p. S112-S113.

Research output: Contribution to journal › Article › peer-review

TY - JOUR

T1 - Survival analysis of first-line tamoxifen versus aromatase inhibitors for estrogen-positive metastatic breast cancer in postmenopausal women - a BC perspective

AU - Kyritsis, V.

AU - De Lemos, M.

AU - Walker, Brian

AU - Kennecke, H.

AU - Nakashima, L.

PY - 2007

Y1 - 2007

M3 - Article

VL - 106

SP - S112-S113

JO - Breast Cancer Research and Treatment

JF - Breast Cancer Research and Treatment

SN - 0167-6806

ER -